Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ambrx Biopharma Inc. (AMAM)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
12.28-0.03 (-0.24%)
At close: 3:59PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/25/2021
Current
Market Cap (intraday) 5
473.88M
Enterprise Value 3
386.61M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
34.66
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
28.28
Enterprise Value/EBITDA 7
-34.61

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-27.80%
S&P500 52-Week Change 337.51%
52 Week High 322.87
52 Week Low 311.03
50-Day Moving Average 313.86
200-Day Moving Average 316.86

Share Statistics

Avg Vol (3 month) 319.13k
Avg Vol (10 day) 314.36k
Shares Outstanding 537.67M
Implied Shares Outstanding 6N/A
Float 89.13k
% Held by Insiders 10.00%
% Held by Institutions 142.72%
Shares Short (Oct 14, 2021) 43.11k
Short Ratio (Oct 14, 2021) 40.15
Short % of Float (Oct 14, 2021) 4N/A
Short % of Shares Outstanding (Oct 14, 2021) 40.01%
Shares Short (prior month Sep 14, 2021) 44.98k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)N/A

Profitability

Profit Margin -121.01%
Operating Margin (ttm)-95.93%

Management Effectiveness

Return on Assets (ttm)-8.38%
Return on Equity (ttm)-23.65%

Income Statement

Revenue (ttm)13.67M
Revenue Per Share (ttm)0.83
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)13.67M
EBITDA -11.17M
Net Income Avi to Common (ttm)-16.54M
Diluted EPS (ttm)-1.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.02
Book Value Per Share (mrq)-5,741.33

Cash Flow Statement

Operating Cash Flow (ttm)-20.58M
Levered Free Cash Flow (ttm)-7.06M
Advertisement
Advertisement